Ripk3 Signaling Restricts the Development of Peripheral T Cell Lymphoma in Tet2 Deficient Mice

被引:0
|
作者
Joshi, Kana [1 ]
Mack, Ryan [1 ]
Zhang, Lei [2 ]
Liu, Shanhui [1 ]
Sellin, Mark [1 ]
Wei, Wei [1 ]
Breslin, Peter [1 ,3 ,4 ]
Kini, Ameet R. [5 ]
Zhang, Jiwang [1 ,6 ]
机构
[1] Loyola Univ, Cardinal Bernardin Canc Ctr, Dept Canc Biol, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Canc Biol, 2160 S 1st Ave, Maywood, IL 60153 USA
[3] Loyola Univ, Med Ctr, Dept Mol Cellular Physiol, Maywood, IL USA
[4] Loyola Univ, Biol, Chicago, IL 60611 USA
[5] Loyola Univ, Med Ctr, Pathol, Maywood, IL USA
[6] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL USA
关键词
D O I
10.1182/blood-2021-147896
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3318
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Loss of Ripk3 signaling promotes T cell lymphoma development in Tet2 deficient mice
    Joshi, Kanak
    Zinzuwadia, Shuchi
    Mack, Ryan
    Zhang, Lei
    Liu, Shanhui
    Sellin, Mark
    Wei, Wei
    Breslin, Peter
    Kini, Ameet R.
    Zhang, Jiwang
    CANCER RESEARCH, 2022, 82 (12)
  • [2] Reduced Tet2 Function Contributes to Development of Peripheral T-Cell Lymphoma with Follicular Helper T-Cell-Like Features in Mice
    Muto, Hideharu
    Sakata-Yanagimoto, Mamiko
    Miyake, Yasuyuki
    Enami, Terukazu
    Kamada, Yuhei
    Kato, Takayasu
    Nishikii, Hidekazu
    Suzukawa, Kazumi
    Nakamura, Naoya
    Ogawa, Seishi
    Chiba, Shigeru
    BLOOD, 2012, 120 (21)
  • [3] Response to Azacytidine in a Patient With Refractory Peripheral T-cell Lymphoma With TET2 Mutation
    Le, Minh-Anh
    Al-Moussally, Feras
    Carilli, Allison
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [4] REDUCED TET2 FUNCTION CONTRIBUTES TO DEVELOPMENT OF PERIPHERAL T-CELL LYMPHOMA THROUGH IMPAIRMENT OF EPIGENETIC REGULATION
    Sakata-Yanagimoto, M.
    Muto, H.
    Nagae, G.
    Miyake, Y.
    Enami, T.
    Kamada, Y.
    Kato, T.
    Nishikii, H.
    Suzukawa, K.
    Nakamura, N.
    Aburatani, H.
    Ogawa, S.
    Chiba, S.
    HAEMATOLOGICA, 2013, 98 : 460 - 460
  • [5] Double somatic mosaic mutations in TET2 and DNMT3A-origin of peripheral T cell lymphoma in a case
    Nguyen, Tran B.
    Sakata-Yanagimoto, Mamiko
    Nakamoto-Matsubara, Rie
    Enami, Terukazu
    Ito, Yufu
    Kobayashi, Toshikata
    Obara, Naoshi
    Hasegawa, Yuichi
    Chiba, Shigeru
    ANNALS OF HEMATOLOGY, 2015, 94 (07) : 1221 - 1223
  • [6] Double somatic mosaic mutations in TET2 and DNMT3A—origin of peripheral T cell lymphoma in a case
    Tran B. Nguyen
    Mamiko Sakata-Yanagimoto
    Rie Nakamoto-Matsubara
    Terukazu Enami
    Yufu Ito
    Toshikata Kobayashi
    Naoshi Obara
    Yuichi Hasegawa
    Shigeru Chiba
    Annals of Hematology, 2015, 94 : 1221 - 1223
  • [7] TET2 and DNMT3A Mutations in Human T-Cell Lymphoma
    Couronne, Lucile
    Bastard, Christian
    Bernard, Olivier A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (01): : 95 - 96
  • [8] Targeting TET2 as a Therapeutic Approach for Angioimmunoblastic T Cell Lymphoma
    Hu, Lina
    Zhang, Xuanye
    Li, Huifeng
    Lin, Suxia
    Zang, Shengbing
    CANCERS, 2022, 14 (22)
  • [9] TET2 Mutation in Adult T-Cell Leukemia/Lymphoma
    Shimoda, Kazuya
    Shide, Kotaro
    Kameda, Takuro
    Hidaka, Tomonori
    Kubuki, Yoko
    Kamiunten, Ayako
    Sekine, Masaaki
    Akizuki, Keiichi
    Shimoda, Haruko
    Yamaji, Takumi
    Nakamura, Kenichi
    Abe, Hiroo
    Miike, Tadashi
    Iwakiri, Hisayoshi
    Tahara, Yoshihiro
    Sueta, Mitsue
    Yamamoto, Shojiro
    Hasuike, Satoru
    Nagata, Kenji
    Kitanaka, Akira
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2015, 55 (03) : 145 - 149
  • [10] Concomitant loss of TET2 and TET3 results in T cell expansion and genomic instability in mice
    Gioulbasani, Marianthi
    Aijo, Tarmo
    Liu, Siyao
    Montgomery, Stephanie A.
    Montgomery, Nathan D.
    Corcoran, David
    Tsagaratou, Ageliki
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)